Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A case of vemurafenib-induced polyarhritis in a patient with melanoma: how to manage it?

International journal of rheumatic diseases - 1 Mar 2017

Babacan Taner, Türkbeyler Ibrahim Halil, Balakan Ozan, Pehlivan Yavuz, Suner Ali, Kısacık Bunyamin

Abstract excerpt

Vemurafenib is an inhibitor of the BRAF V600E mutation which is associated with tumor responses in patients with metastatic melanoma. Although it is generally well tolerated, common side effects of vemurafenib have been reported. Arthralgia is one of the more common adverse event associated with vemurafenib. We herein report a 49-year-old woman diagnosed with metastatic melanoma harboring the BRAF V600E mutation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Inflammatory Agents
Share to Arthritis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Indoles

Share to Melanoma

Share to Skin Neoplasms

Share to Sulfonamides

Share to Ultrasonography

Share to Vemurafenib

Source

Identifiers

PMID: 24815010
DOI: 10.1111/1756-185X.12396

Genes

BRAF

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A case of vemurafenib-induced polyarhritis in a patient with melanoma: how to manage it?PMID 24815010Read ↗

An effective treatment in Erdheim Chester disease: vemurafenib: a case report.Semantic proximity Read ↗

Unexpected recalcitrant course of drug-induced erythema multiforme-like eruption and interstitial pneumonia sequentially occurring after nivolumab therapy.Semantic proximity Read ↗

Ocular toxicity in BRAF mutant cutaneous melanoma patients treated with vemurafenib.Semantic proximity Read ↗

Nonmalignant cutaneous findings associated with vemurafenib.Semantic proximity Read ↗

Spectrum of short-term inflammatory musculoskeletal manifestations after COVID-19 vaccine administration: a report of 66 casesSemantic proximity Read ↗

Acute kidney injury in patients with severe rash on vemurafenib treatment for metastatic melanomas.Semantic proximity Read ↗

Cutaneous toxicities associated with vemurafenib therapy in 107 patients with BRAF V600E mutation-positive metastatic melanoma, including recognition and management of rare presentations.Semantic proximity Read ↗

Knee Arthritis After COVID-19 Vaccination: A Seven-Cases SeriesSemantic proximity Read ↗

Granuloma Annulare Secondary to Vemurafenib Therapy for Lung Adenocarcinoma.Semantic proximity Read ↗

Vemurafenib-induced bilateral facial palsy.Semantic proximity Read ↗

Long-term functional outcomes of diffuse pigmented villonodular synovitis of the knee after synovectomy with or without adjuvant radiotherapySemantic proximity Read ↗

Suspected Warfarin-Induced Leukocytoclastic Vasculitis in a Patient with Double Mechanical Valve Replacement: A Rare Anticoagulation Dilemma in a Resource-Limited Rheumatic SettingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.